DKK1 and Miyoshi myopathy: It has been shown that the inhibitor of the DKK1 pathway can suppress WNT3A-dependent OPG expression in osteoblasts, impairing osteogenesis [26], and artificial stimulation of WNT3A in MM can enhance osteogenesis and reduce tumor growth [41].